Coronavirus Notebook: Six African Countries To Produce mRNA Vaccines, CEPI Funds Indian Candidates
Alvea, a US biotech startup, says its first two DNA vaccine candidates are undergoing “rigorous” preclinical testing and could enter clinical trials as early as April this year.
You may also be interested in...
The Ukrainian pharma firm Darnitsa, which is the latest firm to benefit from the WHO’s mRNA coronavirus vaccine initiative, says it is continuing production amidst the continuing Russian attacks on the country. Meanwhile, the European Medicines Agency has issued guidance for sponsors on methodological aspects of trials affected by the war.
A new list of national regulators that want to be seen as meeting the highest international regulatory standards has been drawn up by the WHO in a drive to foster regulatory convergence and harmonization.
Numerous initiatives are under way to maximize equitable access to COVID-19 products around the world, but most have some drawbacks that need to be addressed if they are to meet their goals, according to the medicines access NGO, WEMOS.